Dr. Schallhorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 San Pablo St
Los Angeles, CA 90033Phone+1 503-494-7674Fax+1 323-442-6338- Is this information wrong?
Education & Training
- University of California (San Francisco)Residency, Ophthalmology, 2010 - 2013
- Huntington Memorial HospitalInternship, Transitional Year, 2009 - 2010
- Keck School of Medicine of the University of Southern CaliforniaClass of 2009
Certifications & Licensure
- OR State Medical License 2014 - Present
- CA State Medical License 2010 - 2024
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Macular Edema Nepafenac vs. Difluprednate Uveitis Trial Start of enrollment: 2018 Sep 12
- Outpatient Performed Pterygium Surgery Study Start of enrollment: 2020 Mar 01
- Azithromycin for Meibomian Gland Disease Start of enrollment: 2018 Sep 01
Publications & Presentations
PubMed
- 104 citationsEnhanced Tomographic Assessment to Detect Corneal Ectasia Based on Artificial Intelligence.Bernardo Lopes, Isaac Ramos, Marcella Q. Salomão, Frederico P. Guerra, Steve Schallhorn
American Journal of Ophthalmology. 2018-11-01 - 12 citationsA national survey of practice patterns: temporal artery biopsy.Julie M. Schallhorn, Sara J. Haug, Michael K. Yoon, Travis C. Porco, Stuart R. Seiff
Ophthalmology. 2013-09-01 - 11 citationsNanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry EyeXiaolan Chen, Sujin Lee, Tianyi Zhang, Tianying Duan, Neel D Pasricha
Journal of Ocular Pharmacology and Therapeutics. 2020-01-14
Authored Content
- Nanothin DSAEK, DMEK Yield Comparable Visual OutcomesFebruary 2019
Press Mentions
- Cataract Surgery After LASIKDecember 9th, 2022
- Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic ConjunctivitisOctober 26th, 2020
- Three-Month Outcomes of Laser Vision Correction for Myopia and Hyperopia in Adults with AmblyopiaAugust 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: